Back to Search Start Over

Sense of smell in chronic rhinosinusitis: a multicentric study on 811 patients

Authors :
Macchi, Alberto
Giorli, Alessia
Cantone, Elena
Carlotta Pipolo, Giorgia
Arnone, Flavio
Barbone, Umberto
Bertazzoni, Giacomo
Bianchini, Chiara
Ciofalo, Andrea
Cipolla, Federica
De Massimi, Alessio
De Vita, Carla
Di Lieto, Cristina
Ghidini, Angelo
Govoni, Marco
Gramellini, Giulia
Maselli Del Giudice, Alessandro
Ottaviano, Giancarlo
Seccia, Veronica
Sireci, Federico
Sollini, Giacomo
Staffieri, Claudia
Gallo, Stefania
Heffler, Enrico
Mantia, Ignazio La
De Corso, Eugenio
Canevari, Frank Rikki
Lombardo, Nicola
Malvezzi, Luca
Orietti, Gabriele
Pasquini, Ernesto
Presutti, Livio
Monti, Giulia
Macchi1, Alberto
Giorli, Alessia
Cantone, Elena
Carlotta Pipolo, Giorgia
Arnone, Flavio
Barbone, Umberto
Bertazzoni, Giacomo
Bianchini, Chiara
Ciofalo, Andrea
Cipolla, Federica
De Massimi, Alessio
De Vita, Carla
Di Lieto, Cristina
Ghidini, Angelo
Govoni, Marco
Gramellini, Giulia
Maselli Del Giudice, Alessandro
Ottaviano, Giancarlo
Seccia, Veronica
Sireci, Federico
Sollini, Giacomo
Staffieri, Claudia
Gallo, Stefania
Heffler, Enrico
La Mantia, Ignazio
De Corso, Eugenio
Rikki Canevari, Frank
Lombardo, Nicola
Malvezzi, Luca
Orietti, Gabriele
Pasquini, Ernesto
Presutti, Livio
Monti, Giulia
Publication Year :
2023
Publisher :
Frontiers Media SA, 2023.

Abstract

IntroductionThe impairment of the sense of smell is often related to chronic rhinosinusitis (CRS) with or without nasal polyps (CRSwNP, CRSsNP). CRSwNP is a frequent condition that drastically worsens the quality of life of those affected; it has a higher prevalence than CRSsNP. CRSwNP patients experience severe loss of smell with earlier presentation and are more likely to experience recurrence of their symptoms, often requiring revision surgery.MethodsThe present study performed a multicentric data collection, enrolling 811 patients with CRS divided according to the inflammatory endotype (Type 2 and non-Type 2). All patients were referred for nasal endoscopy for the assessment of nasal polyposis using nasal polyp score (NPS); Sniffin’ Sticks olfactory test were performed to measure olfactory function, and SNOT-22 (22-item sinonasal outcome test) questionnaire was used to assess patients’ quality of life; allergic status was evaluated with skin prick test and nasal cytology completed the evaluation when available.ResultsData showed that Type 2 inflammation is more common than non-type 2 (656 patients versus 155) and patients suffer from worse quality of life and nasal polyp score. Moreover, 86.1% of patients with Type 2 CRSwNP were affected by a dysfunction of the sense of smell while it involved a lesser percentage of non-Type 2 patients. Indeed, these data give us new information about type-2 inflammation patients’ characteristics.DiscussionThe present study confirms that olfactory function weights on patients’ QoL and it represents an important therapeutic goal that can also improve patients’ compliance when achieved. In a future – and present – perspective of rhinological precision medicine, an impairment of the sense of smell could help the clinician to characterize patients better and to choose the best treatment available.

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.doi.dedup.....99f3d017868dcbeaceff41f856400efb